SCHEMBL985056

SCHEMBL985056

O=C(Nc1ccccc1-c1nc2cccnc2s1)c1cc(O)cc(-c2ccccc2)n1

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
HPGD P15428 2/20 0.52
MAPT P10636 7/20 0.51
TP53 P04637 2/20 0.51
POLB P06746 2/20 0.51
KDM4E B2RXH2 4/20 0.49
MAPK1 P28482 2/20 0.49
ALOX15 P16050 1/20 0.48
HTT P42858 1/20 0.48
THRB P10828 3/20 0.47
AHR P35869 1/20 0.46
LMNA P02545 4/20 0.46
GAA P10253 1/20 0.46
PPARG P37231 1/20 0.44
NR2E3 Q9Y5X4 1/20 0.44
NCOR2 Q9Y618 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL982438 0.84 ALDH1A1 (0.47) ALDH1A1HPGDMAPTTP53POLB
SCHEMBL13855595 0.84 ALDH1A1 (0.47) ALDH1A1HPGDMAPTTP53POLB
SCHEMBL12949153 0.84 ALDH1A1 (0.47) ALDH1A1HPGDMAPTTP53POLB
SCHEMBL12923624 0.82 ALDH1A1 (0.45) ALDH1A1HPGDMAPTTP53POLB
SCHEMBL12923628 0.82 MAPT (0.48) ALDH1A1HPGDMAPTTP53POLB
SCHEMBL12923627 0.82 MAPT (0.47) ALDH1A1HPGDMAPTTP53POLB
SCHEMBL12923607 0.82 ALDH1A1 (0.45) ALDH1A1HPGDMAPTTP53POLB
SCHEMBL13855604 0.82 ALDH1A1 (0.45) ALDH1A1HPGDMAPTTP53POLB
SCHEMBL982847 0.82 KDM4E (0.56) ALDH1A1HPGDMAPTTP53POLB
SCHEMBL12923590 0.82 MAPT (0.47) ALDH1A1HPGDMAPTTP53POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110009381-A1 SOLUBILIZED THIAZOLOPYRIDINES SIRTIS PHARMACEUTICALS, INC. (US) 2011-01-13 US disclosed
US-20110009381-A1 SOLUBILIZED THIAZOLOPYRIDINES SIRTIS PHARMACEUTICALS, INC. (US) 2011-01-13 US disclosed
US-20110009381-A1 SOLUBILIZED THIAZOLOPYRIDINES SIRTIS PHARMACEUTICALS, INC. (US) 2011-01-13 US disclosed
WO-2009061453-A1 SOLUBILIZED THIAZOLOPYRIDINES SIRTRIS PHARMACEUTICALS, INC. (US) 2009-05-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009381-A1 SOLUBILIZED THIAZOLOPYRIDINES SIRT3, SIRT1, SIRT2 ALDH1A1 778/4885HPGD 230/4885MAPT 550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.